The uninsured, tort reform, and the nursing shortage matter, but obesity matters a lot more, according to a group of CEOs that met to hash out what they thought the president-elect's top health priorities should be. The group—which included the CEOs of Pfizer, Novartis, WellPoint and the Mayo Clinic—is part of the WSJ CEO Council, a conference the Wall Street Journal convened in Washington, DC. The looming disease burden associated with the obesity epidemic, and all the costs and suffering it will entail, apparently pushed it ahead of other, frequently discussed health-reform issues.